Taisho Pharmaceutical Holdings Co Ltd ADR TAIPY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $12.00
- Day Range
- $12.00–12.00
- 52-Week Range
- $8.88–15.52
- Bid/Ask
- $7.99 / $13.75
- Market Cap
- $144.00
- Volume/Avg
- 1,520 / 1,459
Key Statistics
- Price/Earnings (Normalized)
- 31.14
- Price/Sales
- —
- Dividend Yield (Trailing)
- 1.43%
- Dividend Yield (Forward)
- 1.43%
- Total Yield
- 234,982.50%
Company Profile
Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 9,540
- Website
- http://www.taisho-holdings.co.jp
Comparables
Valuation
|
Metric
|
TAIPY
|
4554
|
4547
|
|---|---|---|---|
Price/Earnings (Normalized) | 31.14 | 7.56 | 40.87 |
Price/Book Value | — | 0.90 | 0.81 |
Price/Sales | — | 0.91 | 2.24 |
Price/Cash Flow | — | 3.91 | 42.44 |
Price/Earnings
TAIPY
4554
4547
Financial Strength
|
Metric
|
TAIPY
|
4554
|
4547
|
|---|---|---|---|
Quick Ratio | 4.20 | 0.68 | 4.22 |
Current Ratio | 5.16 | 1.46 | 5.93 |
Interest Coverage | 68.75 | 55.27 | 875.67 |
Quick Ratio
TAIPY
4554
4547
Profitability
|
Metric
|
TAIPY
|
4554
|
4547
|
|---|---|---|---|
Return on Assets (Normalized) | 2.57% | 3.39% | 2.02% |
Return on Equity (Normalized) | 3.09% | 7.02% | 2.33% |
Return on Invested Capital (Normalized) | 2.64% | 4.22% | 1.76% |
Return on Assets
TAIPY
4554
4547
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Ydppmwzmq | Mthrr | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Lfcdkqpff | Hkm | $68.9 Bil | |
HLN
| Haleon PLC ADR | Ytjbdzxc | Vjxp | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Ycmnszmy | Qth | $14.8 Bil | |
VTRS
| Viatris Inc | Zxqblyyrm | Jhtyt | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Vpvrbpqf | Fzcx | $11.9 Bil | |
CTLT
| Catalent Inc | Hhfmvgyy | Xhvhqws | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Szqlbyt | Qpnp | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Smgjjcl | Dngk | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Gnskywylv | Vkydkl | $3.5 Bil |